Retina Institute Japan, a venture company of RIKEN, starts industrialization of pigment epithelium retina (RPE) cell transplants derived from iPS cells for treatment of age-related macular degeneration

https://rijapan.jp/

Retina Institute Japan, press release June 20, 2012

Retina Institute Japan, a venture company of RIKEN, starts industrialization of pigment epithelium retina (RPE) cell transplants derived from iPS cells for treatment of age-related macular degeneration
Scroll to top